
Enteric Disease Testing Market by Pathogen Tested (Campylobacter, Clostridium, E. coli), Technology (Chromatography & Spectrometry, Immunoassay, Polymerase Chain Reaction), End-Use - Global Forecast 2024-2030
Description
Enteric Disease Testing Market by Pathogen Tested (Campylobacter, Clostridium, E. coli), Technology (Chromatography & Spectrometry, Immunoassay, Polymerase Chain Reaction), End-Use - Global Forecast 2024-2030
The Enteric Disease Testing Market size was estimated at USD 2.28 billion in 2023 and expected to reach USD 2.41 billion in 2024, at a CAGR 6.44% to reach USD 3.53 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Enteric Disease Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Enteric Disease Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Alere, Inc., Als Limited, Asure Quality, Becton, Dickinson and Company, BIO-RAD Laboratories, Inc., Bureau Veritas Group, Eurofins Scientific, Hardy Diagnostics, Intertek Group plc, Merck KGAA, Mérieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., and TÜV SÜD.
Market Segmentation & Coverage
This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Pathogen Tested
Campylobacter
Clostridium
E. coli
Enterobacteriaceae
Hepatitis A, B, & E
Listeria
Norovirus
Rotavirus
Salmonella
Shigella
Vibrio
Technology
Chromatography & Spectrometry
Immunoassay
Polymerase Chain Reaction
Rapid
Traditional
End-Use
Food
Cereals & Grain
Dairy products
Fruits & Vegetables
Herbs & Spices
Meat, Poultry, & Seafood
Nuts
Processed Food
Water
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Enteric Disease Testing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Enteric Disease Testing Market?
3. What are the technology trends and regulatory frameworks in the Enteric Disease Testing Market?
4. What is the market share of the leading vendors in the Enteric Disease Testing Market?
5. Which modes and strategic moves are suitable for entering the Enteric Disease Testing Market?PDF E-mail From Publisher (2-5)Users License
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Enteric Disease Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rise in demand for convenience foods and ready to go foods
- 5.1.1.2. Increase prevalence of enteric diseases
- 5.1.1.3. Surging awareness among individuals about the benefits of early diagnosis
- 5.1.2. Restraints
- 5.1.2.1. High cost regarding testing of food and water in developing economies
- 5.1.3. Opportunities
- 5.1.3.1. Emergence of technological innovations in the enteric disease testing
- 5.1.3.2. Favorable government regulations and reimbursement policies
- 5.1.4. Challenges
- 5.1.4.1. Lack of proper regulations governing pathogen testing in the developing economies
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Enteric Disease Testing Market, by Pathogen Tested
- 6.1. Introduction
- 6.2. Campylobacter
- 6.3. Clostridium
- 6.4. E. coli
- 6.5. Enterobacteriaceae
- 6.6. Hepatitis A, B, & E
- 6.7. Listeria
- 6.8. Norovirus
- 6.9. Rotavirus
- 6.10. Salmonella
- 6.11. Shigella
- 6.12. Vibrio
- 7. Enteric Disease Testing Market, by Technology
- 7.1. Introduction
- 7.2. Chromatography & Spectrometry
- 7.3. Immunoassay
- 7.4. Polymerase Chain Reaction
- 7.5. Rapid
- 7.6. Traditional
- 8. Enteric Disease Testing Market, by End-Use
- 8.1. Introduction
- 8.2. Food
- 8.3.1. Cereals & Grain
- 8.3.2. Dairy products
- 8.3.3. Fruits & Vegetables
- 8.3.4. Herbs & Spices
- 8.3.5. Meat, Poultry, & Seafood
- 8.3.6. Nuts
- 8.3.7. Processed Food
- 8.3. Water
- 9. Americas Enteric Disease Testing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Enteric Disease Testing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Enteric Disease Testing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. 3M Company
- 13.1.2. Alere, Inc.
- 13.1.3. Als Limited
- 13.1.4. Asure Quality
- 13.1.5. Becton, Dickinson and Company
- 13.1.6. BIO-RAD Laboratories, Inc.
- 13.1.7. Bureau Veritas Group
- 13.1.8. Eurofins Scientific
- 13.1.9. Hardy Diagnostics
- 13.1.10. Intertek Group plc
- 13.1.11. Merck KGAA
- 13.1.12. Mérieux NutriSciences Corporation
- 13.1.13. Neogen Corporation
- 13.1.14. Nova Biologicals
- 13.1.15. Perkinelmer, Inc.
- 13.1.16. Romer Labs Division Holding GmbH
- 13.1.17. SGS SA
- 13.1.18. Symbio Laboratories
- 13.1.19. Thermo Fisher Scientific Inc.
- 13.1.20. TÜV SÜD
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
- FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
- FIGURE 7. ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2023 VS 2030 (%)
- FIGURE 8. ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 10. ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 12. ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.